Molecular alterations in metastatic breast cancer and efficacy of PI3K/AKT/mTOR inhibitors in early phase clinical trials

Tesis doctoral

Fecha de lectura10 jul 2017
Idioma originalIndefinido/desconocido
Institución de lectura
  • Hospital Universitario Vall d'Hebron (HUVH)
SupervisorJordi Giralt Lopez de Sagredo (Director/a) & Jordi Giralt Lopez de Sagredo (Tutor/a)

Citar esto

'